This is not the first time that the industry has grabbed PE attention. In August last year, PE Hub covered 7 deals in the ...
2h
The Punch on MSNGlo to honour late NBA legendNigerian telecom operator, Globacom, has revealed plans to celebrate the late Congolese-American basketball legend and philanthropist, Dikembe Mutombo, on the Cable News Network International’s ...
Bezos has a lot on the line, especially for his rocket maker Blue Origin. He’s competing for government contracts with Trump BFF Elon Musk, who owns rival SpaceX. People close to Bezos dispute the ...
It's official - space is a war-fighting domain. Who says so? The British, the Americans, Nato and, among many other nations, ...
Next, we’ll look at carve-outs, a frequent topic here on PE Hub. The latest PE firm to get involved is Mérieux Equity Partners, which has acquired a majority stake in Curea Medical, a carve-out from ...
Tales of Autumn (RedDeer.Games, 20th Mar, $2.99) - Tales of Autumn is a wild farming RPG with an emphasis on animals and ...
Satellite images from space are allowing scientists to delve deeper into the individual functions of different tropical forest canopies with new and surprising results. Understanding tree traits and ...
Success is built on ambition, resilience, and the ability to create something iconic. DC Singh, a successful British businessman, has ...
Opinion
9hOpinion
Worldcrunch on MSNTrump, The Arsonist — Reviving The Archetype Of Destroyer As Shaper Of HistoryDriven by a relentless pursuit of spectacle, Donald Trump embodies the "destructive character" — a figure who reshapes history through chaos and upheaval. But is destruction itself enough to sustain ...
9h
Independent.ie on MSNMaking a show of herself: Mary Kate O’Flanagan turns life’s chaos into comedy in DroghedaThere’s an alchemy to live storytelling that only the best performers can conjure, a rare blend of humour, heartache and humanity that makes an audience laugh, cry and most importantly, feel seen.
Amid Trump’s dismantling of DEI, Roche wiped diversity targets from the website of its US subsidiary, Genentech, in mid-February. Basel-based competitor Novartis also said this week it was getting rid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results